PASG
Passage Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.65
−2.11%Sep 3, 2026, 10:14 UTC
Passage BIO, Inc. amended and restated its merger agreement with Remix Therapeutics, Inc., changing the structure to a two-step merger and permitting the concurrent financing to be funded through pre-funded warrants.
Jun 24, 2026, 20:05 UTC
Passage Bio and Remix Therapeutics announced a merger agreement, with the combined company to operate as Remix Therapeutics and advance Remix's pipeline of novel small molecule therapies.
Source: